Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: A win-win bet with Health Authorities!

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) pandemic virus was a “health crisis” and a significant burden also for the French pharmacovigilance system. It took its toll in 2 phases, the first being in early 2020 when very little was known, and during which the missions of the 31...

Descripción completa

Detalles Bibliográficos
Autores principales: Jonville-Bera, Annie Pierre, Gautier, Sophie, Micallef, Joëlle, Massy, Nathalie, Atzenhoffer, Marina, Grandvuillemin, Aurélie, Drici, Milou-Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2023
Materias:
Pharmacovigilance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990876/
https://www.ncbi.nlm.nih.gov/pubmed/37012154
http://dx.doi.org/10.1016/j.therap.2023.03.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990876/
https://www.ncbi.nlm.nih.gov/pubmed/37012154
http://dx.doi.org/10.1016/j.therap.2023.03.002

Ejemplares similares